| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |